StockData
Aspire-Lakewood Holdings, Inc. logo

Aspire-Lakewood Holdings, Inc. (ASBP) stock

ASBPNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as ASBPW
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026Score 2/30
$7.89−0.41 (-4.94%)

Close on Nov 18, 2026Market cap $11.07MP/E –Yield –

Aspire-Lakewood net income

Net income is the profit left for shareholders after every expense, interest and tax.

Aspire-Lakewood's net income for the twelve months ending Jun 30, 2026 was -$11.05M. For fiscal 2025 it was -$24.48M.

Annual net income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$24.48M–
FY2024Dec 31, 2024-$1.31M-129.3%
FY2023Dec 31, 2023$4.46M+33.6%
FY2022Dec 31, 2022$3.34M–

Quarterly net income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$1.27M–
Q1 FY2026Mar 31, 2026-$3.22M–
Q4 FY2025Dec 31, 2025-$4.71M–
Q3 FY2025Sep 30, 2025-$1.85M–
Q2 FY2025Jun 30, 2025-$1.98M–
Q1 FY2025Mar 31, 2025-$15.94M–
Q4 FY2024Dec 31, 2024-$765.71K–
Q3 FY2024Sep 30, 2024-$216.27K–
Q2 FY2024Jun 30, 2024-$96.92K-105.3%
Q1 FY2024Mar 31, 2024-$230.97K-108.0%
Q4 FY2023Dec 31, 2023-$150.91K-106.8%
Q3 FY2023Sep 30, 2023-$69.26K-106.4%
Q2 FY2023Jun 30, 2023$1.81M+1401.2%
Q1 FY2023Mar 31, 2023$2.87M–
Q4 FY2022Dec 31, 2022$2.23M–
Q3 FY2022Sep 30, 2022$1.08M–
Q2 FY2022Jun 30, 2022$120.69K–
Q1 FY2022Mar 31, 2022-$87.83K–
Q3 FY2021Sep 30, 2021-$15.31K–
Q2 FY2021Jun 30, 2021-$2.38K–

More Aspire-Lakewood figures

See a number that looks wrong?